Cassava Sciences Inc financial data

Symbol
SAVA on Nasdaq
Industry
Pharmaceutical Preparations
Location
6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
PAIN THERAPEUTICS INC (to 3/25/2019)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 389 % -76%
Debt-to-equity 9.41 % +159%
Return On Assets -8.5 % +79.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48M shares +14.3%
Common Stock, Shares, Outstanding 48M shares +14.4%
Entity Public Float 967M USD -12.1%
Common Stock, Value, Issued 48K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 46.2M shares +10.6%
Weighted Average Number of Shares Outstanding, Diluted 46.2M shares +10.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 73.8M USD -39.1%
General and Administrative Expense 58.2M USD +307%
Operating Income (Loss) -132M USD -35.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -15.4M USD +82.9%
Earnings Per Share, Basic -0.4 USD/shares
Earnings Per Share, Diluted 0.13 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 207M USD +23.1%
Other Assets, Current 161K USD -43.9%
Assets, Current 222M USD +27.3%
Property, Plant and Equipment, Net 21.4M USD -4.32%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 82K USD -78.8%
Assets 244M USD +23.5%
Accounts Payable, Current 10.3M USD +117%
Employee-related Liabilities, Current 218K USD -0.91%
Accrued Liabilities, Current 7.04M USD +112%
Liabilities, Current 54.6M USD +205%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 14.2M USD +94.6%
Retained Earnings (Accumulated Deficit) -350M USD -4.6%
Stockholders' Equity Attributable to Parent 189M USD +5.36%
Liabilities and Equity 244M USD +23.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.1M USD -44.3%
Net Cash Provided by (Used in) Financing Activities 22.2M USD +34525%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 48M shares +14.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 168M USD -14.6%
Deferred Tax Assets, Valuation Allowance 77.3M USD +43.2%
Deferred Tax Assets, Gross 77.3M USD +43.2%
Operating Lease, Liability 139K USD -41.1%
Depreciation 1.03M USD +3.82%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 143K USD -41.6%
Property, Plant and Equipment, Gross 24.1M USD +0.3%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 36K USD -66.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 107K USD +4.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4K USD -55.6%
Deferred Tax Assets, Operating Loss Carryforwards 33.3M USD +18.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.41M USD +29.5%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 538M USD +4.87%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 325K USD -31.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 8.02M USD +209%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%